The DOI matches its Crossref record; 113 of the 113 references it cites were found in a registry or an index.
Management of Cocaine Abuse and Dependence
Abstract
During the 20th century, there have been recurrent episodes of cocaine abuse in the United States that have achieved epidemic proportions.1 Although the total number of people using the drug has decreased in the past decade, cocaine-related biomedical and psychosocial problems remain a major public health problem in the United States and many other countries. The expanding list of cocaine-related toxic effects, acute and chronic, includes reproductive dysfunction, hepatic necrosis, and pulmonary disease.2 Abuse of and dependence on cocaine may also be associated with disorders of sexual function, sleep, anxiety, and mood, as well as with delirium and psychotic disorders. . . .
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Persistent postwithdrawal disorders have been described with different classes of CNS drugs (e.g.protracted insomnia for alcohol and benzodiazepine withdrawal [10,36] and major depression/dysphoria for cocaine and amphetamine withdrawal [10,23] ), and even more so with specific drugs (e.g.quetiapine and paroxetine) within a drug class [6,15,16,33] .”
From New Classification of Selective Serotonin Reuptake Inhibitor Withdrawal (2015) · cites this paper as [16]
In the citing paper
“We now have increasing evidence for postwithdrawal disorders with SSRI long-term use [6,15,16,26,37] .”
From New Classification of Selective Serotonin Reuptake Inhibitor Withdrawal (2015) · cites this paper as [16]
In the citing paper
“Data from controlled trials [15,20,29] , case reports [16] , and online patient reports [26] show that paroxetine is most likely to be associated with new withdrawal symptoms, and fluoxetine the least.”
From New Classification of Selective Serotonin Reuptake Inhibitor Withdrawal (2015) · cites this paper as [16]
In the citing paper
“According to most studies [1,15,16,20,29] , even with gradual tapering, withdrawal symptoms still occur.”
From New Classification of Selective Serotonin Reuptake Inhibitor Withdrawal (2015) · cites this paper as [16]
In the citing paper
“Fava et al. [16] conducted a study of gradual SSRI discontinuation in panic disorder and found that 9 of 20 patients (45%) experienced new withdrawal symptoms, and that 3 of the 9 (33%) patients treated with paroxetine had postwithdrawal disorders at 1 year of follow-up, including bipolar spectrum disorder (n = 2) and major depressive disorder (n = 1).”
From New Classification of Selective Serotonin Reuptake Inhibitor Withdrawal (2015) · cites this paper as [16]
In the citing paper
“They may resemble rebound symptoms being more severe than the original symptoms, but these disorders persist at least 6 weeks in contrast to rebound symptoms and [6,15,16,26,37] .”
From New Classification of Selective Serotonin Reuptake Inhibitor Withdrawal (2015) · cites this paper as [16]
In the citing paper
“Persistent postwithdrawal panic disorder [15,38] has been shown to occur following withdrawal of paroxetine, and paroxetine has also been associated with other postwithdrawal disorders [6,15,16] .”
From New Classification of Selective Serotonin Reuptake Inhibitor Withdrawal (2015) · cites this paper as [16]
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
An Improved Diagnostic Evaluation Instrument for Substance Abuse Patients
McLellan, A. T., Luborsky, L. B., WOODY, G. E., & Brien, C. P. O. (1980) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-198001000-00006 · Cited by 3,163
Cocaine Receptors on Dopamine Transporters Are Related to Self-Administration of Cocaine
Ritz, M. C., Lamb, R. J., Goldberg, S. R., & Kuhar, M. J. (1987) · Science · doi:10.1126/science.2820058 · Cited by 2,180
Cellular and molecular mechanisms of drug dependence
Koob, G. F., & Bloom, F. E. (1988) · Science · doi:10.1126/science.2903550 · Cited by 2,070
Naltrexone in the Treatment of Alcohol Dependence
Volpicelli, J. R. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820110040006 · Cited by 1,828
Naltrexone and Coping Skills Therapy for Alcohol Dependence
O’Malley, S. S. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820110045007 · Cited by 1,476
[Drug addiction and drug abuse].
Feuerlein, W. (1969) · PubMed · Cited by 1,415
Abstinence Symptomatology and Psychiatric Diagnosis in Cocaine Abusers
Gawin, F. H. (1986) · Archives of General Psychiatry · doi:10.1001/archpsyc.1986.01800020013003 · Cited by 1,143
The dopamine hypothesis of the reinforcing properties of cocaine
Kuhar, M. J., Ritz, M. C., & Boja, J. W. (1991) · Trends in Neurosciences · doi:10.1016/0166-2236(91)90141-g · Cited by 1,005
Gawin, F. H., & Ellinwood, E. H. (1988) · New England Journal of Medicine · doi:10.1056/nejm198805053181806 · Cited by 965
Research works printed but not linked: 22
- Musto DF. The American disease: origins of narcotic control. New Haven, Conn.: Yale University Press, 1973.
- Mendelson JH, Mello NK. Cocaine and other commonly abused drugs. In: Isselbacher KJ, Braunwald E, Wilson JD, Martin JB, Fauci AS, Kasper DL, eds. Harrison's principles of internal medicine. 13th ed. New York: McGraw-Hill, 1994:2429-33.
- National Institute on Drug Abuse. Epidemiologic trends in drug abuse. Vol. 1. Highlights and executive summary. Washington, D.C.: Government Printing Office, 1995. (NIH publication no. 95-3988.)
- Johanson CE, 1989, Pharmacol Rev, 41, 3
- Foltin RW, 1991, J Pharmacol Exp Ther, 257, 247
- McCance EF, 1995, J Pharmacol Exp Ther, 274, 215
- Holman BL, 1991, J Nucl Med, 32, 1206
- Gawin FH, 1988, J Clin Psychiatry, 49, 11
- Millman R, 1988, J Clin Psychiatry, 49, 27
- Mendelson JH, 1992, J Pharmacol Exp Ther, 263, 505
- Mello NK, 1990, J Pharmacol Exp Ther, 254, 815
- Mello NK, 1993, J Pharmacol Exp Ther, 266, 804
- Covi L, 1994, Clin Pharmacol Ther, 55, 132
- Kosten TR, 1987, J Clin Psychiatry, 48, 442
- Kuhar MJ, 1993, Pharmacologist, 35, 28
- Kosten TR, 1988, Am J Psychiatry, 145, 381
- Preston KL, 1993, J Pharmacol Exp Ther, 267, 296
- Kreek MJ. Multiple drug abuse patterns and medical consequences. In: Meltzer HY, ed. Psychopharmacology: the third generation of progress. New York: Raven Press, 1987:1597-604.
- Mendelson JH, Albeck J. Naloxone modification of acute alcohol intoxication in humans. In: Proceedings of the 39th Annual Scientific Meeting, Committee on Problems of Drug Dependence, Cambridge, Mass, July 1977. Washington, D.C.: Committee on Problems of Drug Dependence, 1978:572-82.
- Mendelson JH, 1992, Neuropsychopharmacology, 7, 157
- Gastfriend DR, 1993, Am J Addict, 2, 269
- Gastfriend DR, Mendelson JH, Mello NK, et al. Longitudinal dose comparisons of buprenorphine for combined opiate and cocaine dependence. In: Harris LS, ed. Problems of drug dependence, 1995: proceedings of the 57th Annual Scientific Meeting, the Committee on Problems of Drug Dependence, Inc. NIDA research monograph. Washington, D.C.: Government Printing Office (in press).
Cited by
Sorted by citations
Items 101–200 of 295
Grimm, J. W., Harkness, J. H., Ratliff, C. A., Barnes, J., North, K., & Collins, S. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2210-y · Cited by 54
Factors modulating the incubation of drug and non-drug craving and their clinical implications
Vènniro, M., Reverte, I., Ramsey, L. A., Papastrat, K. M., D’Ottavio, G., Milella, M. S., Li, X., Grimm, J. W., & Caprioli, D. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.09.050 · Cited by 58
Oxytocin and neuroadaptation to cocaine
Sarnyai, Z. (1999) · Progress in brain research · doi:10.1016/s0079-6123(08)61587-3 · Cited by 51
Zheng, F., Yang, W., Liu, X., Hou, S., Liu, J., & Zhan, C. (2010) · Biochemistry · doi:10.1021/bi1011628 · Cited by 50
Zheng, F., & Zhan, C. (2012) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002610 · Cited by 50
Fluorescent Cocaine Probes: A Tool for the Selection and Engineering of Therapeutic Antibodies
Meijler, M. M., Kaufmann, G. F., Qi, L., Mee, J. M., Coyle, A. R., Moss, J. A., Wirsching, P., Matsushita, M., & Janda, K. D. (2005) · Journal of the American Chemical Society · doi:10.1021/ja043935e · Cited by 48
The Effects of Chronic Cocaine Self-Administration on the Menstrual Cycle in Rhesus Monkeys
Mello, N. K., Mendelson, J. H., Kelly, M., Diaz-Migoyo, N., & Sholar, J. W. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36607-8 · Cited by 47
Self-citationMello, N. K., & Negus, S. S. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37431-2 · Cited by 47
Self-citationCocaine triggers epigenetic alterations in the corticostriatal circuit
Sadri‐Vakili, G. (2014) · Brain Research · doi:10.1016/j.brainres.2014.09.069 · Cited by 50
Platt, D. M., Rowlett, J. K., & Spealman, R. D. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39328-0 · Cited by 46
Ball, K. T., & Slane, M. M. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2762-5 · Cited by 42
Effect of flupenthixol on subjective and cardiovascular responses to intravenous cocaine in humans
Evans, S. M., WALSH, S. L., LEVIN, F. R., Foltin, R. W., Fischman, M. W., & Bigelow, G. E. (2001) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(01)00129-6 · Cited by 45
Serotonergic mechanisms in addiction-related memories
Dhonnchadha, B. Á. N., & Cunningham, K. A. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.06.026 · Cited by 44
Grimm, J. W., Barnes, J. L., Koerber, J., Glueck, E., Ginder, D. E., Hyde, J., & Eaton, L. (2015) · Brain Structure and Function · doi:10.1007/s00429-015-1074-z · Cited by 44
Brand love and brand addiction and their effects on consumers' negative behaviors
Junaid, M. R., Fetscherin, M., Hussain, K., & Hou, F. (2022) · European Journal of Marketing · doi:10.1108/ejm-09-2019-0727 · Cited by 56
Ball, K. T., Wellman, C. L., Fortenberry, E., & Rebec, G. V. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.02.025 · Cited by 43
Burattini, C., Burbassi, S., Aicardi, G., & Cervo, L. (2007) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145707007705 · Cited by 43
McCracken, C. B., & Grace, A. A. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.1440-13.2013 · Cited by 43
Models of intervention and care for psychostimulant users
Baker, A., Lee, N., & Jenner, L. (2004) · Cited by 42
Long-lasting rewarding effects of morphine induced by drug primings
Couto, B. R. D., Aguilar, M. A., Rodríguez‐Arias, M., & Miñarro, J. (2005) · Brain Research · doi:10.1016/j.brainres.2005.05.023 · Cited by 41
Reinstatement of MDMA (ecstasy) seeking by exposure to discrete drug-conditioned cues
Ball, K. T., Walsh, K. M., & Rebec, G. V. (2007) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2007.05.018 · Cited by 41
Role of serotonin (5-HT)1B receptors in psychostimulant addiction
Joanna, M. W., Filip, M., & Przegaliński, E. (2011) · Pharmacological Reports · doi:10.1016/s1734-1140(11)70695-8 · Cited by 40
Topiramate in opiate withdrawal
ZULLINO, D. F., Eskenasy, A. C., & Besson, J. (2002) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(02)00251-8 · Cited by 40
Effects of serotonin (5-HT)1B receptor ligands on amphetamine-seeking behavior in rats
Miszkiel, J., & Przegaliński, E. (2013) · Pharmacological Reports · doi:10.1016/s1734-1140(13)71062-4 · Cited by 40
Negus, S. S., & Mello, N. K. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.300.3.1111 · Cited by 40
Self-citationCornish, J. L., Lontos, J. M., Clemens, K. J., & McGregor, I. S. (2005) · Psychopharmacology · doi:10.1007/s00213-004-2135-9 · Cited by 41
Behavioral evaluation of modafinil and the abuse-related effects of cocaine in rhesus monkeys.
Newman, J. L., Negus, S. S., Lozama, A., Prisinzano, T. E., & Mello, N. K. (2010) · Experimental and Clinical Psychopharmacology · doi:10.1037/a0021042 · Cited by 39
Self-citationCocaine, Hormones, and Behavior: Clinical and Preclinical Studies
Mello, N. K., & Mendelson, J. H. (2009) · Elsevier eBooks · doi:10.1016/b978-008088783-8.00098-x · Cited by 39
Self-citationPHARMACOLOGIC TREATMENTS FOR DRUG AND ALCOHOL DEPENDENCE
Kranzler, H. R., Amin, H., Modesto‐Lowe, V., & Oncken, C. A. (1999) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(05)70084-8 · Cited by 38
Graphene-Based Electrochemical Sensors for Psychoactive Drugs
Boroujerdi, R., & Paul, R. (2022) · Nanomaterials · doi:10.3390/nano12132250 · Cited by 38
Differential modulation of behavioral effects of cocaine by low- and high-efficacy D 1 agonists
Spealman, R. D., Bergman, J., & Rosenzweig-Lipson, S. J. (1997) · Psychopharmacology · doi:10.1007/s002130050403 · Cited by 38
Negus, S. S., Brandt, M. R., & Mello, N. K. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35071-2 · Cited by 38
Self-citationIdentification and Characterization of Single Chain Anti-cocaine Catalytic Antibodies
McKenzie, K. M., Mee, J. M., Rogers, C. J., Hixon, M. S., Kaufmann, G. F., & Janda, K. D. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.10.031 · Cited by 36
Dickerson, T. J., & Janda, K. D. (2005) · The AAPS Journal · doi:10.1208/aapsj070359 · Cited by 36
RetractedSubstance abuse in adolescents: a complex conundrum for the clinician.
Greydanus, D., & Patel, D. R. (2003) · The Pediatric clinics of North America · doi:10.1016/s0031-3955(03)00079-8 · Cited by 37
Stevens, K. E., Kem, W. R., & Freedman, R. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00200-0 · Cited by 35
[Toxicology of local anesthetics. Clinical, therapeutic and pathological mechanisms].
Zink, W., & Graf, B. M. (2003) · PubMed · doi:10.1007/s00101-003-0617-5 · Cited by 34
Negus, S., & Mello, N. (2004) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2004.01.006 · Cited by 34
Self-citationSun, W., Zelek-Molik, A., & McGinty, J. F. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3118-5 · Cited by 34
Caine, S. B., Negus, S. S., Mello, N. K., & Bergman, J. (2000) · Experimental and Clinical Psychopharmacology · doi:10.1037//1064-1297.8.3.404 · Cited by 33
Self-citationCorticostriatal microRNAs in addiction
Heyer, M. P., & Kenny, P. J. (2015) · Brain Research · doi:10.1016/j.brainres.2015.07.047 · Cited by 32
Brunetto, M. D. R., Delgado, Y., Clavijo, S., Contreras, Y., Torres, D., Ayala, C., Gallignani, M. A., Forteza, R., & Martín, V. C. (2010) · Journal of Separation Science · doi:10.1002/jssc.200900833 · Cited by 31
Wong, C. J., Anthony, S., Sigmon, S., Mongeon, J. A., Badger, G., & Higgins, S. (2004) · Experimental and clinical psychopharmacology · doi:10.1037/1064-1297.12.3.190 · Cited by 29
Mello, N. K., Mendelson, J. H., Sholar, M. B., Jaszyna-Gasior, M., Goletiani, N. V., & Siegel, A. J. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300631 · Cited by 31
Self-citationNallamothu, B. K., Saint, S. K., Kolias, T. J., & Eagle, K. A. (2001) · New England Journal of Medicine · doi:10.1056/nejm200108023450508 · Cited by 31
Sun, W., Coleman, N. T., Zelek-Molik, A., Barry, S. M., Whitfield, T. W., & McGinty, J. F. (2013) · Addiction Biology · doi:10.1111/adb.12043 · Cited by 32
Cavazos‐Rehg, P. A., Spitznagel, E. L., Schootman, M., Strickland, J. R., Afful, S. E., Cottler, L. B., & Bierut, L. J. (2009) · AIDS Patient Care and STDs · doi:10.1089/apc.2008.0272 · Cited by 30
Gancarz, A. M., Adank, D. N., & Dietz, D. (2014) · Scientific Reports · doi:10.1038/srep06876 · Cited by 31
Treatment Retention of Crack and Cocaine Users in a National Sample of Long Term Residential Clients
Rowan‐Szal, G. A., Joe, G. W., & Simpson, D. D. (2000) · Addiction Research & Theory · doi:10.3109/16066350009004409 · Cited by 30
Sitharthan, T., Singh, S., Kranitis, P., Currie, J., Freeman, P., Murugesan, G., & Ludowici, J. (1999) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/j.1440-1614.1999.00621.x · Cited by 30
Psychomotor stimulant effects of β-phenylethylamine in monkeys treated with MAO-B inhibitors
Bergman, J., Yaşar, S., & Winger, G. D. (2001) · Psychopharmacology · doi:10.1007/s002130100890 · Cited by 30
Herman, B. H., & O’Brien, C. P. (1997) · Seminars in Neuroscience · doi:10.1006/smns.1997.0115 · Cited by 30
The Role of DNA Methylation in Drug Addiction: Implications for Diagnostic and Therapeutics
Lax, E., & Moshe Szyf, A. (2018) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2018.01.003 · Cited by 29
Mixed Kappa/Mu Partial Opioid Agonists as Potential Treatments for Cocaine Dependence
Bidlack, J. M. (2014) · Advances in pharmacology · doi:10.1016/b978-0-12-420118-7.00010-x · Cited by 28
Dickerson, T. J., Kaufmann, G. F., & Janda, K. D. (2005) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.5.6.773 · Cited by 29
Manchikanti, L. (2004) · Pain Physician · doi:10.36076/ppj.2004/7/339 · Cited by 29
Medications for Alcohol, Illicit Drug, and Tobacco Dependence
Litten, R. Z., & Allen, J. P. (1999) · Journal of Substance Abuse Treatment · doi:10.1016/s0740-5472(98)00028-2 · Cited by 29
Concurrent Pharmacokinetic Analysis of Plasma Cocaine and Adrenocorticotropic Hormone in Men1
Sholar, M. B., Mendelson, J. H., Mello, N. K., Siegel, A. J., Kaufman, M. J., Levin, J. M., Renshaw, P. F., & Cohen, B. M. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.3.4654 · Cited by 29
Self-citationBarker, D. J., Bercovicz, D., Servilio, L. C., Simmons, S. J., Ma, S., Root, D. H., Pawlak, A. P., & West, M. O. (2013) · Addiction Biology · doi:10.1111/adb.12044 · Cited by 28
Cocaine Rapid Efficacy Screening Trials (CREST): lessons learned
Kampman, K. M., Leiderman, D. B., Holmes, T. H., LoCastro, J. S., Bloch, D. A., Reid, M. S., SHOPTAW, S. J., Montgomery, M. A., Winhusen, T. M., Somoza, E. C., et al. (2005) · Addiction · doi:10.1111/j.1360-0443.2005.00987.x · Cited by 28
Puig, S., Noble, F., & Benturquia, N. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.103 · Cited by 28
Neumeyer, J. L., Gu, X., van Vliet, L. A., DeNunzio, N. J., Rusovici, D. E., Cohen, D. J., Negus, S. S., Mello, N. K., & Bidlack, J. M. (2001) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)00543-1 · Cited by 28
Self-citationCocaine, Hormones, and Behavior
Mello, N. K., & Mendelson, J. H. (2002) · Elsevier eBooks · doi:10.1016/b978-012532104-4/50106-2 · Cited by 28
Self-citationReaction Pathway and Free Energy Profile for Cocaine Hydrolase-Catalyzed Hydrolysis of (−)-Cocaine
Liu, J., & Zhan, C. (2012) · Journal of Chemical Theory and Computation · doi:10.1021/ct200810d · Cited by 27
Direct fluorescence anisotropy assay for cocaine using tetramethylrhodamine-labeled aptamer
Liu, Y., & Zhao, Q. (2017) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-017-0349-z · Cited by 27
DENTAL CARE OF PATIENTS WITH SUBSTANCE ABUSE
Bullock, K. (1999) · Dental Clinics of North America · doi:10.1016/s0011-8532(22)00806-0 · Cited by 27
Cohen, P. J. (1997) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(97)00075-6 · Cited by 27
An ecological approach to exploring factors affecting substance use relapse: a systematic review
Barati, M., Bashirian, S., Mohammadi, Y., Moeini, B., Mousali, A., & Afshari, M. (2021) · Journal of Public Health · doi:10.1007/s10389-020-01412-x · Cited by 26
Agmatine blocks acquisition and re-acquisition of intravenous morphine self-administration in rats
Su, R., Wang, W.-P., Lu, X., Wu, N., Liu, Z., & Li, J. (2009) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2009.03.009 · Cited by 26
Postoperative analgesia in patients with substance use disorders: Part II
Jage, J., & Bey, T. A. (2000) · Acute Pain · doi:10.1016/s1366-0071(00)80021-2 · Cited by 25
Platt, D. M., Rodefer, J. S., Rowlett, J. K., & Spealman, R. D. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1347-0 · Cited by 26
Provencher, B. A., Sromek, A. W., Li, W., Russell, S. E., Chartoff, E. H., Knapp, B. I., Bidlack, J. M., & Neumeyer, J. L. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm401290y · Cited by 25
Yang, W., Pan, Y., Fang, L., Gao, D., Zheng, F., & Zhan, C. (2010) · The Journal of Physical Chemistry B · doi:10.1021/jp104989b · Cited by 25
Swalve, N. L., Smethells, J. R., Zlebnik, N. E., & Carroll, M. E. (2016) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2016.03.008 · Cited by 25
A cost-effective fluorescence biosensor for cocaine based on a “mix-and-detect” strategy
Wu, Z., Zhou, H. H., Han, Q.-J., Lin, X.-L., Han, D., & Li, X. (2020) · The Analyst · doi:10.1039/d0an00675k · Cited by 25
Changes in extracellular dopamine during cocaine self‐administration in squirrel monkeys
Kimmel, H. L., Ginsburg, B. C., & Howell, L. L. (2005) · Synapse · doi:10.1002/syn.20135 · Cited by 25
Newton, T. F., Garza, R. D. L., Fong, T., Chiang, N., Holmes, T. H., Bloch, D. A., Anderson, A., & Elkashef, A. M. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.11.012 · Cited by 25
Xie, S.-J., Zhou, H. H., Liu, D., Shen, G., Yu, R., & Wu, Z. (2013) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2013.01.017 · Cited by 24
Lee, S. H., Park, S. J., Kim, I. S., & Jung, Y. H. (2012) · Tetrahedron · doi:10.1016/j.tet.2012.12.044 · Cited by 24
CRF1 receptor-deficiency increases cocaine reward
Contarino, A., Kitchener, P., Vallée, M., Papaleo, F., & Piazza, P. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.01.024 · Cited by 26
Kampman, K. M., Rukstalis, M. R., Ehrman, R. N., McGinnis, D. E., Gariti, P., Volpicelli, J. R., Pettinati, H. M., & O’Brien, C. P. (1999) · Addictive Behaviors · doi:10.1016/s0306-4603(98)00040-9 · Cited by 24
Dobrovitsky, V., Pimentel, P., Duarte, A., Froestl, W., Stellar, J. R., & Trzcińska, M. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00007-2 · Cited by 24
Disruption of model-based behavior and learning by cocaine self-administration in rats
Wied, H. M., Jones, J. L., Cooch, N. K., Berg, B. A., & Schoenbaum, G. M. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3222-6 · Cited by 26
Solmi, M., Dragioti, E., Croatto, G., Raduà, J., Borgwardt, S., Carvalho, A. F., Demurtas, J., Mosina, A., Kurotschka, P. K., Shin, J. I., et al. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.03.014 · Cited by 22
Dâ€TMAscenzo, M., Podda, M. V., & Grassi, C. (2014) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2014.00016 · Cited by 24
Novel pharmacotherapies for cocaine abuse 1997 - 2000
Newman, A. H. (2000) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.10.7.1095 · Cited by 23
Computational design of a thermostable mutant of cocaine esterase via molecular dynamics simulations
Huang, X., Gao, D., & Zhan, C. (2011) · Organic & Biomolecular Chemistry · doi:10.1039/c0ob00972e · Cited by 22
Mello, N., & Negus, S. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301319 · Cited by 20
Self-citationPeripartum care of the cocaine-abusing parturient: are we ready?
Kuczkowski, K. M. (2005) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1080/j.0001-6349.2005.00487.x · Cited by 22
Wang, J., Song, J., Wang, X., Wu, S., Zhao, Y., Luo, P., & Meng, C. (2016) · Talanta · doi:10.1016/j.talanta.2016.08.039 · Cited by 22
Mello, N. K. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00247-5 · Cited by 22
Self-citationHiggins, S. T., & Wong, C. J. (1998) · Elsevier eBooks · doi:10.1016/b978-012347360-8/50016-1 · Cited by 22
Topiramate in Opiate Withdrawal-Comparison with Clonidine and with Carbamazepine/Mianserin
ZULLINO, D. F., Krenz, S., Zimmermann, G., Miozzari, A., Rajeswaran, R., Kolly, S., & Khazaal, Y. (2005) · Substance Abuse · doi:10.1300/j465v25n04_04 · Cited by 21
Knackstedt, L. A., & Schwendt, M. (2016) · Neural Plasticity · doi:10.1155/2016/9312508 · Cited by 21
Drug Discrimination in Methamphetamine-Trained Monkeys: Effects of Monoamine Transporter Inhibitors
Czoty, P. W., Ramanathan, C. R., Mutschler, N. H., Makriyannis, A., & Bergman, J. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.071035 · Cited by 21
Liu, J., Zhao, X., Yang, W., & Zhan, C. (2011) · The Journal of Physical Chemistry B · doi:10.1021/jp200975v · Cited by 20
Cocaína: aspectos farmacológicos
Lizasoaín, I., Moro, M. A., & Lorenzo, P. D. (2002) · Adicciones · doi:10.20882/adicciones.513 · Cited by 20
Kotani, M., Kiyoshi, A., Murai, T., Nakako, T., Matsumoto, K., Matsumoto, A., Ikejiri, M., Ogi, Y., & Ikeda, K. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.11.028 · Cited by 22
Liu, X., Hou, S., Yang, W., Fang, L., Zheng, F., & Zhan, C. (2012) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2012.08.003 · Cited by 19
Integration of research in pharmacotherapy for addictive disease: Where are we? Where are we going?
Ling, W. W., & SHOPTAW, S. J. (1997) · Journal of Addictive Diseases · doi:10.1080/10550889709511145 · Cited by 19
Metadata
- Authors
- Mendelson, J. H., & Mello, N. K.
- Affiliations
- Harvard University (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1996-04-11
- Volume
- 334
- Issue
- 15
- Pages
- 965-972
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2338649220
- Cited by
- 291
- References
- 112
- Citations by year
- 2024: 4 · 2023: 4 · 2022: 4 · 2021: 3 · 2020: 2 · 2019: 1 · 2018: 3 · 2017: 4 · 2016: 8 · 2015: 7 · 2014: 9 · 2013: 20 · 2012: 14
- FWCI
- 5.15
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r18da006116-05)
- National Institute on Drug Abuse (DA 06116, K05DA000064, KO5-DA 00101, KO5 DA 00064, K05DA000101)
- Topics
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Youth, Drugs, and Violence
- Keywords
- cocaine abuse, cocaine dependence, cocaine toxicity, reproductive disorders, liver necrosis, lung disease, sexual dysfunction, sleep disorders, anxiety, mood disorders, delirium, psychosis
- MeSH terms
- Antidepressive Agents, Carbamazepine, Cocaine, Humans, Narcotic Antagonists, Narcotics, Dopamine Agents, Substance-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
